首页> European journal of human genetics : EJHG> Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.

Prevalent versus incident breast cancers: benefits of clinical and radiological monitoring in women with pathogenic BRCA1/2 variants.

导出 OA

翻译打印收藏纠错

第一作者： Claire,Saule

第一单位： Institut Curie, Department of Genetics, PSL Research University, Paris, France. claire.saule@curie.fr.

作者： Claire,Saule ^[1] ; Solveig,Menu-Hespel ^[2] ; Matthieu,Carton ^[3] ; Caroline,Malhaire ^[4] ; Pascal,Cherel ^[5] ; Fabien,Reyal ^[6] ; Marine,Le Mentec ^[7] ; Eugénie,Guillot ^[8] ; Anne,Donnadieu ^[9] ; Nasrine,Callet ^[10] ; Sophie,Frank ^[11] ; Florence,Coussy ^[12] ; Dominique,Stoppa-Lyonnet ^[13] ; Emmanuelle,Mouret-Fourme ^[7]

作者单位： Institut Curie, Department of Genetics, PSL Research University, Paris, France. claire.saule@curie.fr. ^[1] CHU, Department of Genetics, Lille, France. ^[2] Institut Curie, Department of Biometry, DRCI, PSL Research University, Paris, France. ^[3] Institut Curie, Department of Medical Imaging, PSL Research University, Paris, France.;Institut Curie, INSERM, LITO Laboratory, 91401, Orsay, France. ^[4] Institut Curie, Department of Medical Imaging, Saint-Cloud, France. ^[5] Institut Curie, Department of Surgery, PSL Research University, Paris, France.;Institut Curie, Residual Tumour & Response to Treatment Laboratory (RT2Lab), INSERM, U 932 Immunity and Cancer, Paris, France. ^[6] Institut Curie, Department of Genetics, PSL Research University, Paris, France. ^[7] Institut Curie, Department of Surgery, Saint-Cloud, France. ^[8] Institut Curie, Department of Medical Oncology, Saint-Cloud, France. ^[9] Institut Curie, Department of Genetics, PSL Research University, Paris, France.;Institut Curie, Department of Medical Oncology, Saint-Cloud, France. ^[10] Institut Curie, Department of Genetics, PSL Research University, Paris, France.;Institut Curie, Department of Medical Oncology, PSL Research University, Paris, France. ^[11] Institut Curie, Department of Medical Oncology, PSL Research University, Paris, France. ^[12] Institut Curie, Department of Genetics, PSL Research University, Paris, France.;Institut Curie, INSERM U830, Paris, France.;Université de Paris, Paris, France. ^[13]